Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-20

Clinical Trial Update: Intrahepatic HCV RNA and Telaprevir Kinetics in Hepatitis C Virus (HCV) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating intrahepatic HCV RNA and pharmacokinetics of telaprevir in Hepatitis C. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Incivek (telaprevir)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2015-03-20